Procter & Gamble Articles
P&G wins patent infringement case over Actonel
15 May 2009
P&G looking to sell pharma operations
16 February 2009
Ablynx takes P&G program in-house
26 January 2009
Stock Commentary - New York week to Dec 15, 2008
22 December 2008
FDA finds no AF link for bisphosphonates
24 November 2008
Shire's Lialda shows sustained 5-ASA release
13 October 2008
$14.7M funding deal for SpePharm
8 September 2008
Noven in global deal with P&G on HSDD patch
1 September 2008
JHP/SpePharm acquire rights to Dantrium
1 September 2008
NOS slams NICE rules on 2nd-line osteo drugs
14 July 2008
P&G ends collaboration on ARYx' ATI-7505
7 July 2008
CORRECTION: P&G's Asacol trial
25 February 2008
P&G's Asacol launched in UK for UC
18 February 2008
German drug price fixing penalties
21 January 2008
Final OK for OTC omeprazole, and Perrigo ups guidance
17 December 2007
P&G reports strong UC data on Asacol
17 December 2007
UK's PMCPA names six firms in violation of Code
17 December 2007
First patients recruited into trial of P&G's Asacol
3 December 2007
Teva gains final OK for generic Actonel
15 October 2007
P&G's 800mg Asacol MR cleared in UK for acute UC and Crohn
15 October 2007
FDA warns P&G on unlawful marketing
24 September 2007
Actonel halves risk of hip fracture recurrence
24 September 2007
Boeh Ing and Ablynx sign development deal
17 September 2007
Chi-Med's 1st-half net loss widens to $5.6M
20 August 2007
Ablynx identifies novel Nanobodies under P&G deal
25 June 2007
European pharma television channel coming soon?
28 May 2007
Japan stock market week to April 23, 2007
30 April 2007
Japan approves once-weekly risedronate
30 April 2007
Asacol improves quality of life for UC patients
11 December 2006
S-P and Teva sign UK Mesren promotion deal
13 November 2006
Big Pharma needs to catch up with specialty detailing
18 September 2006
Stock Commentary - New York week to Aug 7, 2006
14 August 2006
LTKfarma established in France
17 July 2006
Actavis launches five new products in USA
17 July 2006
Nastech and P&G collaborate on PTH1-34 nasal spray
12 June 2006
Ablynx to extend Procter & Gamble Pharma R&D accord
17 April 2006
Stock Commentary - New York week to Feb 13, 2006
20 February 2006
Celsis Labs wins P&G and Mutual Pharma contracts
13 February 2006
Pfizer considers selling consumer unit
13 February 2006
Nastech signs PTH1-34 accord with P&G
6 February 2006
FDA OKs Sanofi/P&G's Actonel with Calcium
22 August 2005
Teva gets tentative appro for risedronate
22 August 2005
Evotec in deal with P&G for discovery services
1 August 2005
Novartis to develop Enablex in USA with P&G
18 July 2005
Hans van Zoonen becomes president of AEGSP
11 July 2005
Buyers line up for Boots' OTC business
20 June 2005
Alexion's 3rd-qtr loss leaps on soaring costs
13 June 2005
UK guide for industry on Rx access in DCs
4 April 2005
SAFE biopharma digital identity standard move
21 February 2005
Highlights of pharmaceutical mergers and acquisitions in 2004
24 January 2005
TaiGen and P&G enter development deal
17 January 2005
Stock Commentary - New York
13 December 2004
P&G's Intrinsa rejected by FDA panel
13 December 2004
Novavax reaffirms clinical strategy for Androsorb
13 December 2004
Procter & Gamble's 1st-qtr EPS climbs 16%
1 November 2004
Alexion's fiscal-2004 net loss down 12%
4 October 2004
P&G's Intrinsa gets FDA priority review
27 September 2004
Mylan withdraws law suit against FDA
6 September 2004
PPIs lead growth in $2.5B US OTC gastro market
23 August 2004
Stock Commentary - New York
26 July 2004
Ablynx and P&GP in nanobody drug deal
26 July 2004
Aventis' Actonel under threat by Teva
26 July 2004
FDA OKs new trials for pexelizumab
21 June 2004
Genzyme grants P&G exclusive RDP58 licence
12 April 2004
Watson launches generic Macrobid
29 March 2004
InnoCentive and NCL announce partnership
29 March 2004
Stock Commentary - New York
22 March 2004
Grupo Vita denies approach from P&G
1 March 2004
Aventis lines up "white knights"
9 February 2004
Options for a P&G/Aventis link-up reviewed by broker Natexis
26 January 2004
Stock Commentary - Europe
26 January 2004
Aventis-Sanofi merger rumors grow, despite firm's denials
26 January 2004
Aventis' shares up on P&G takeover rumor
19 January 2004
Noven earns $500,000 milestone from P&G Pharma
5 January 2004
Sequenom signs accord with P&G
5 January 2004
New study shows impact of osteoporosis
24 November 2003
P&G Prilosec claim on end of injunction
29 September 2003
P&G's Actonel helps preserve bone quality
29 September 2003
P&G plans large Prilosec debut in USA
22 September 2003
US insurers move on generics, OTCs
22 September 2003
Teva set to contest Fosamax court ruling
8 September 2003
Alexion
11 August 2003
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
